Stock Price Quote

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE602.90-1.2 (-0.2 %)
PREV CLOSE ( ) 604.10
OPEN PRICE ( ) 611.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 60288
TODAY'S LOW / HIGH ( )601.00 611.70
52 WK LOW / HIGH ( )386.85 660.9
NSE603.05-0.65 (-0.11 %)
PREV CLOSE( ) 603.70
OPEN PRICE ( ) 607.10
BID PRICE (QTY) 603.05 (127)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1493001
TODAY'S LOW / HIGH( ) 600.60 609.95
52 WK LOW / HIGH ( )385.45 660.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 2005
Management Info
Ravindranath Kancherla - Chairman - Managing Director
Registered Office

Address Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli,
Vishakhapatnam,
Andhra Pradesh-531021

Phone 0891 6821101 / 1102

Email info@lauruslabs.com

Website www.lauruslabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

15Apr Laurus Labs gets EIR for API manufactu
Laurus Labs has received the Establishment Inspection Report (EIR) for i..
15Apr Laurus Labs jumps on getting EIR for A
Laurus Labs is currently trading at Rs. 619.60, up by 13.50 points or 2...
28Mar Laurus Labs gets nod to acquire up to
Laurus Labs has received approval to acquire up to 26% of share capital..
17Mar Laurus Labs acquires equity shares in
Laurus Labs has invested Rs 83.30 crore and acquired 83,300,000 equity s..
17Mar Laurus Labs rises on acquiring equity
Laurus Labs is currently trading at Rs. 578.65, up by 5.20 points or 0.9..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit25193803.9
Gross Profit 3302 5038.1
Operating Profit 4669.910448
Net Sales 16500.152169.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  30560.85 (0.62%)
M.Cap ( in Cr)64939.67
Divi's Lab (BSE)
peergroup  6281.35 (1.16%)
M.Cap ( in Cr)166750.11
Medplus Health Servi (BSE)
peergroup  887.25 (8.45%)
M.Cap ( in Cr)10619.84
Wockhardt (BSE)
peergroup  1329.20 (3.49%)
M.Cap ( in Cr)21597.58
Jubilant Pharmova (BSE)
peergroup  945.50 (4.37%)
M.Cap ( in Cr)15060.03

Shareholding Pattern

MUTUAL FUNDS/UTI 6.88%
NON-INSTITUTION 35.09%
FI/BANKS/INSURANCE 3.63%
PROMOTERS 27.62%
GOVERNMENT 0%
FII 0%

About Laurus Labs Ltd.

Laurus Labs Ltd. was incorporated in the year 2005. Its today's share price is 602.9. Its current market capitalisation stands at Rs 32511.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 48123.9 Cr and Total Income of Rs.48598.1 Cr. The company's management includes Ramesh Subrahmanian, Lakshmana Rao CV, Karnam Sekar, Rajesh Koshy Chandy, Aruna Bhinge, Soumya Chava, Krishna Chaitanya Chava, V Ravi Kumar, Satyanarayana Chava, Ravindranath Kancherla, G Venkateswar Reddy.

It is listed on the BSE with a BSE Code of 540222 , NSE with an NSE Symbol of LAURUSLABS and ISIN of INE947Q01028. It's Registered office is at Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, AnakapalliVishakhapatnam-531021, Andhra Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.